Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Chlorpheniramine Mixture With Hydrocodone
2. 131219-97-1
3. Vituz
4. Tuzistra Xr
5. Tussionex Pennkinetic
6. S-t Forte 2
7. Tussicaps Extended-release
8. Tussionex
9. Chlorpheniramine / Hydrocodone
10. Chlorpheniramine Polistirex / Hydrocodone Polistirex
11. Chlorpheniramine Polistirex And Hydrocodone Polistirex
12. Hydrocodone Polistirex And Chlorpheniramine Polistirex
13. Schembl2522788
14. Dtxsid50156960
15. Hydrocodone Conbination Product 15 Mg/du
| Molecular Weight | 574.1 g/mol |
|---|---|
| Molecular Formula | C34H40ClN3O3 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 6 |
| Exact Mass | 573.2758198 g/mol |
| Monoisotopic Mass | 573.2758198 g/mol |
| Topological Polar Surface Area | 54.9 Ų |
| Heavy Atom Count | 41 |
| Formal Charge | 0 |
| Complexity | 758 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 6 | |
|---|---|
| Drug Name | Hydrocodone polistirex and chlorpheniramine polistirex |
| Active Ingredient | Chlorpheniramine polistirex; hydrocodone polistirex |
| Dosage Form | Suspension, extended release |
| Route | Oral |
| Strength | eq 10mg bitartrate/5ml; eq 8mg maleate/5ml |
| Market Status | Prescription |
| Company | Tris Pharma |
| 2 of 6 | |
|---|---|
| Drug Name | Tussicaps |
| Active Ingredient | Chlorpheniramine polistirex; hydrocodone polistirex |
| Dosage Form | Capsule, extended release |
| Route | Oral |
| Strength | eq 10mg bitartrate; eq 5mg bitartrate; eq 4mg maleate; eq 8mg maleate |
| Market Status | Prescription |
| Company | Ecr Pharma |
| 3 of 6 | |
|---|---|
| Drug Name | Tussionex pennkinetic |
| PubMed Health | Hydrocodone and Chlorpheniramine Polistirex (Oral route) |
| Drug Classes | Antitussive, Opioid/Antihistamine Combination, Chlorpheniramine |
| Active Ingredient | Chlorpheniramine polistirex; hydrocodone polistirex |
| Dosage Form | Suspension, extended release |
| Route | Oral |
| Strength | eq 10mg bitartrate/5ml; eq 8mg maleate/5ml |
| Market Status | Prescription |
| Company | Ucb |
| 4 of 6 | |
|---|---|
| Drug Name | Hydrocodone polistirex and chlorpheniramine polistirex |
| Active Ingredient | Chlorpheniramine polistirex; hydrocodone polistirex |
| Dosage Form | Suspension, extended release |
| Route | Oral |
| Strength | eq 10mg bitartrate/5ml; eq 8mg maleate/5ml |
| Market Status | Prescription |
| Company | Tris Pharma |
| 5 of 6 | |
|---|---|
| Drug Name | Tussicaps |
| Active Ingredient | Chlorpheniramine polistirex; hydrocodone polistirex |
| Dosage Form | Capsule, extended release |
| Route | Oral |
| Strength | eq 10mg bitartrate; eq 5mg bitartrate; eq 4mg maleate; eq 8mg maleate |
| Market Status | Prescription |
| Company | Ecr Pharma |
| 6 of 6 | |
|---|---|
| Drug Name | Tussionex pennkinetic |
| PubMed Health | Hydrocodone and Chlorpheniramine Polistirex (Oral route) |
| Drug Classes | Antitussive, Opioid/Antihistamine Combination, Chlorpheniramine |
| Active Ingredient | Chlorpheniramine polistirex; hydrocodone polistirex |
| Dosage Form | Suspension, extended release |
| Route | Oral |
| Strength | eq 10mg bitartrate/5ml; eq 8mg maleate/5ml |
| Market Status | Prescription |
| Company | Ucb |
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
A HYDROCODONE POLISTIREX manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of HYDROCODONE POLISTIREX, including repackagers and relabelers. The FDA regulates HYDROCODONE POLISTIREX manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. HYDROCODONE POLISTIREX API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A HYDROCODONE POLISTIREX supplier is an individual or a company that provides HYDROCODONE POLISTIREX active pharmaceutical ingredient (API) or HYDROCODONE POLISTIREX finished formulations upon request. The HYDROCODONE POLISTIREX suppliers may include HYDROCODONE POLISTIREX API manufacturers, exporters, distributors and traders.
HYDROCODONE POLISTIREX Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of HYDROCODONE POLISTIREX GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right HYDROCODONE POLISTIREX GMP manufacturer or HYDROCODONE POLISTIREX GMP API supplier for your needs.
A HYDROCODONE POLISTIREX CoA (Certificate of Analysis) is a formal document that attests to HYDROCODONE POLISTIREX's compliance with HYDROCODONE POLISTIREX specifications and serves as a tool for batch-level quality control.
HYDROCODONE POLISTIREX CoA mostly includes findings from lab analyses of a specific batch. For each HYDROCODONE POLISTIREX CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
HYDROCODONE POLISTIREX may be tested according to a variety of international standards, such as European Pharmacopoeia (HYDROCODONE POLISTIREX EP), HYDROCODONE POLISTIREX JP (Japanese Pharmacopeia) and the US Pharmacopoeia (HYDROCODONE POLISTIREX USP).
LOOKING FOR A SUPPLIER?
